← FDA Drug Approvals (Drugs@FDA)
NILOTINIB HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2026-06-26
Drug application
- FDA Application #
ANDA219134- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NILOTINIB HYDROCHLORIDE
- Generic name
- Nilotinib Hydrochloride
- Active ingredients
- NILOTINIB HYDROCHLORIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMS INC
- First approval
- 2026-06-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown